Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
ID: 357021Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357021

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-221.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)" aimed at supporting interdisciplinary research to enhance public awareness and develop interventions that address the relationship between alcohol consumption and cancer risk. The initiative focuses on changing social norms, evaluating alcohol policy approaches, and implementing population-level interventions, particularly targeting underrepresented minority populations who experience disparities related to alcohol use and cancer. This funding opportunity is critical as alcohol is a significant preventable risk factor for various cancers, and traditional individual-level interventions have proven inadequate. Applications will be accepted starting January 5, 2025, with a maximum project period of five years, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The application deadline is set for January 7, 2027.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-221-Full-Announcement.html
    PAR-25-221.html
    The Department of Health and Human Services, through the National Institutes of Health, has issued a Notice of Funding Opportunity (NOFO) titled "Population Approaches to Reducing Alcohol-related Cancer Risk" (PAR-25-221). This initiative seeks to fund interdisciplinary research focused on public awareness and interventions aimed at reducing the risks of alcohol consumption related to cancer. The target areas include changing social norms, evaluating alcohol policy approaches, and developing population-level interventions addressing varying levels of alcohol consumption, particularly among underrepresented minority groups. The funding aims to contribute to better cancer prevention strategies and tackle alcohol-related health disparities, as alcohol is a significant preventable risk factor for various cancers. Applications can be submitted starting January 5, 2025, with deadlines for scientific merit review occurring from February to July 2025. Organizations, including higher education institutions and nonprofits, are encouraged to apply, with a maximum project period of five years. The funding opportunity underscores the necessity of innovative population-based approaches, as traditional individual-level interventions have proven insufficient in mitigating the complexities surrounding alcohol consumption and cancer risk. Overall, this funding initiative represents a commitment to enhancing public health through targeted research and intervention strategies.
    Similar Opportunities
    Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Population Approaches to Reducing Alcohol-related Cancer Risk" funding opportunity, designated as R01 Clinical Trial Optional. This initiative aims to support interdisciplinary research focused on increasing awareness of the link between alcohol consumption and cancer risk, altering social norms regarding alcohol use, evaluating alcohol policy approaches, and developing population-level interventions to mitigate alcohol-related cancer risks. The funding is particularly relevant for addressing alcohol use disorders and disparities faced by underrepresented minority populations, with applications due between January 5, 2024, and October 5, 2026, and project periods extending up to five years. There is no specific budget limit for applications, which should reflect the actual needs of the proposed projects. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-244.html.
    Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)" aimed at supporting research projects that evaluate policies related to tobacco, alcohol, and cannabis use in the United States. The initiative focuses on understanding how these policies impact substance use and secondhand exposure among populations experiencing health disparities, with an emphasis on community engagement to enhance cancer prevention efforts. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and government entities, with funding available up to $500,000 per year for a maximum of five years. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for January 7, 2028.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R01 Clinical Trial Optional)" aimed at addressing the treatment gap for individuals with Alcohol Use Disorder (AUD). This initiative focuses on five key areas: increasing access to treatment, enhancing the appeal of treatment options, analyzing cost structures and insurance systems, studying the dissemination of evidence-based practices, and reducing health disparities among affected populations. The program encourages innovative research designs and participation from diverse organizations, with a maximum budget of $500,000 available for direct costs over a five-year project period. Interested applicants can submit proposals starting January 5, 2025, and should direct inquiries to grantsinfo@nih.gov for further information.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a Notice of Funding Opportunity (NOFO) titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)." This initiative aims to enhance the HIV prevention toolkit for populations affected by alcohol consumption, focusing on the integration of effective prevention and treatment interventions to reduce the incidence of new HIV infections. The program is particularly relevant for high-risk groups, including men who have sex with men, transgender individuals, and others impacted by alcohol-related HIV transmission, emphasizing the need for innovative strategies to address health disparities. The funding opportunity offers a total estimated program funding of $1.5 million for 2-4 awards, with individual project budgets capped at $450,000, and applications are due by May 7, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and should refer to the full announcement for detailed application guidelines.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at expanding HIV prevention strategies among populations affected by alcohol use. This initiative encourages research projects that explore the relationship between alcohol consumption and HIV risk behaviors, focusing on areas such as Pre-exposure Prophylaxis (PrEP) utilization, Treatment as Prevention (TasP), and the integration of preventive intervention strategies. The program is particularly significant for addressing health disparities among high-risk groups, including men who have sex with men (MSM) and women with high-risk partners. The NIH anticipates funding between $2 million for 2 to 4 awards, with a project period of up to five years. Interested applicants can submit their proposals through the NIH ASSIST system or Grants.gov, and should direct inquiries to grantsinfo@nih.gov. The application deadline is May 7, 2026.
    Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)" aimed at supporting policy research projects that investigate the impact of tobacco, alcohol, and cannabis policies on health disparities in the U.S. The initiative seeks exploratory research that engages community organizations to promote equity in cancer prevention by addressing substance use and exposure among disadvantaged populations. This grant program, with an estimated total funding of $200,000 and an award ceiling of $200,000, emphasizes the importance of community partnerships and diverse research team perspectives. Applications are due by January 7, 2028, and interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-241.html.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at enhancing the HIV/AIDS prevention toolkit for populations impacted by alcohol use. This initiative seeks to integrate effective prevention and treatment interventions while developing and testing new strategies to address the behavioral and biological risks associated with HIV acquisition, particularly among high-risk groups such as men who have sex with men and transgender individuals. The anticipated funding for fiscal year 2025 is $2 million, with 2-4 awards expected, and applications must be submitted through Grants.gov by May 7, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAS-25-208.html.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Alcohol Treatment, Pharmacotherapy, and Recovery Research grant, specifically under the R01 Clinical Trial Required mechanism. This funding opportunity aims to advance research on Alcohol Use Disorder (AUD) by focusing on various aspects such as medication development, behavioral therapies, recovery mechanisms, and innovative treatment technologies. The NIH emphasizes the importance of addressing AUD, particularly for underserved populations, and seeks projects that translate neuroscience research into practical applications. Interested applicants can apply for a grant with an award ceiling of $500,000, with the application process opening on January 5, 2025, and submissions due by September 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PA-25-163.html.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)" aimed at expanding the HIV/AIDS prevention toolkit among populations impacted by alcohol use. This grant seeks to support research that integrates effective prevention and treatment interventions while addressing the behavioral and biological risks associated with alcohol consumption, particularly among high-risk groups. The initiative is crucial for informing the design of future clinical trials focused on HIV prevention, with an anticipated funding amount of approximately $1.5 million for 2-4 awards. Interested applicants, including higher education institutions and community organizations, must submit their proposals by September 7, 2025, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.